TRCT
GCTK icon

Tower Research Capital (TRC)’s GlucoTrack GCTK Stock Holding History

Tower Research Capital (TRC)’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1K Hold
229
– – ﹤0.01% 4889
2026
Q1 		$2.24K Buy
229
+201
+718% +$6.4K ﹤0.01% 4513
2025
Q4 		$1.65K Sell
28
-26
-48% -$2.31K ﹤0.01% 4663
2025
Q3 		$5.31K Sell
54
-64
-54% -$5.79K ﹤0.01% 4246
2025
Q2 		$10.6K Buy
+118
New +$15.6K ﹤0.01% 3940
2025
Q1 		– Hold
0
– -$403 – 5410
2024
Q4 		– Hold
0
– – – 5284
2024
Q3 		– Hold
0
– – – 5214
2023
Q1 		– Hold
0
– – – 5976
2022
Q4 		– Hold
0
– – – 6066
2022
Q3 		– Hold
0
– – – 6210
2022
Q2 		– Hold
0
– – – 6219

Other funds holding GCTK

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GIPW
Granite Islands Private Wealth Guilford, Connecticut $135M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tower Research Capital (TRC)'s GCTK Position: Q2 2026 in Review

Tower Research Capital (TRC) held its GlucoTrack (GCTK) position steady in Q2 2026 at 229 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4889.

Tower Research Capital (TRC) first reported a position in GCTK in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.6K in Q2 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

  • Tower Research Capital (TRC) held 229 shares of GlucoTrack worth $1.1K as of Q2 2026.
  • Tower Research Capital (TRC) left its GlucoTrack share count unchanged in Q2 2026.
  • GlucoTrack made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4889 holding.
  • Tower Research Capital (TRC) first reported a position in GlucoTrack in Q2 2025 and has held it in 5 quarters since.
  • Tower Research Capital (TRC)'s GlucoTrack position peaked at $10.6K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.